Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
10/2012
10/16/2012CA2576749C Alternative synthesis of renin inhibitors and intermediates thereof
10/16/2012CA2573129C Process for preparing levofloxacin or its hydrate
10/11/2012WO2012138945A1 Methods of treating schizophrenia with pyrazole derivative inhibitors of tgf - beta
10/11/2012WO2012137870A1 Novel imidazo-oxazine compound or salt thereof
10/11/2012WO2012136751A1 N-substituted hetero-bicyclic compounds and derivatives for combating animal pests
10/11/2012US20120258993 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents
10/11/2012US20120258973 Disubstituted heteroaryl-fused pyridines
10/11/2012US20120258949 Spirocyclic derivatives as histone deacetylase inhibitors
10/11/2012US20120258947 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
10/11/2012US20120258166 Rifaximin compositions and method of use
10/11/2012CA2830367A1 Novel imidazo-oxazine compound or salt thereof
10/11/2012CA2830311A1 N-substituted hetero-bicyclic compounds and derivatives for combating animal pests
10/10/2012EP2507246A1 Polymorphous forms iii and iv of n-benzoyl staurosporine
10/10/2012EP2506716A1 Novel tricyclic compounds
10/10/2012CN1934116B Tricyclic benzopyran compound as anti-arrhythmic agents
10/10/2012CN102725287A 1,3,4-oxadiazole-2-carboxamide compound
10/10/2012CN102725269A Synthetic intermediate of oxazole compound and method for producing the same
10/10/2012CN102718777A Method for preparing iodo sirolimus crystals
10/10/2012CN102718776A Total synthesis of salinosporamide A and analogs thereof
10/10/2012CN102718775A Macrocyclic quinazoline derivatives as antiproliferative agents
10/09/2012US8283360 Bicyclic heterocyclic derivatives and methods of use thereof
10/04/2012WO2012131629A1 A process for preparation of intermediate of moxifloxacin
10/04/2012WO2012131096A1 Novel heterocyclic compounds as modulators of sphingolipid signaling and uses thereof
10/04/2012WO2012131019A1 Regioselective acylation of rapamycin at the c-42 position
10/04/2012US20120253039 Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
10/04/2012US20120252799 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/04/2012US20120252785 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
10/04/2012US20120252780 Bicyclic pyridines and analogs as sirtuin modulators
10/04/2012US20120252779 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
10/04/2012US20120251920 Benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the polymer, electrolyte membrane for fuel cell including the polymer, and fuel cell using the electrode
10/04/2012US20120251497 Inhibitors of hepatitis c virus
10/04/2012CA2828829A1 Regioselective acylation of rapamycin at the c-42 position
10/03/2012EP2505589A1 Novel sphingolipid heterocyclic compounds as modulators of sphingolipid signaling and uses thereof
10/03/2012EP2504010A1 Fused bicyclic pyrimidine derivatives and methods of use thereof
10/03/2012CN102712802A Polylactic acid composition
10/03/2012CN102712657A Antimicrobial compounds and methods of making and using the same
10/03/2012CN102702226A Preparation of novel spirooxazine compound and photochromic property improvement thereof
10/03/2012CN102702225A Four-phenolic fluorene based benzoxazine and preparation method of four-phenolic fluorine based benzoxazine
10/03/2012CN101675044B Epoxy compound and method for manufacturing the same
10/02/2012US8278348 Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof
10/02/2012US8278314 Quinazoline analogs as receptor tyrosine kinase inhibitors
10/02/2012CA2575720C Pyrimidine derivatives
09/2012
09/27/2012WO2012127505A2 Improved process for the preparation of ciprofloxacin and its acid addition salts
09/27/2012WO2012126901A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012US20120245347 Compounds and Derivatives of 2H-Pyrido (3,2-b)(1, 4) Oxazin 3)4H)-Ones as raf Kinase and LRRK2 Inhibitors
09/27/2012US20120245345 Tricyclic antibiotics
09/27/2012US20120245175 Mk2 inhibitors
09/27/2012US20120245167 Arthropod pest control method and composition
09/27/2012US20120245162 Oxadiazole inhibitors of leukotriene production
09/27/2012US20120245161 Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors
09/27/2012US20120245160 Polymorphous forms iii and iv of n-benzoyl - staurosporine
09/27/2012US20120245158 Gamma secretase modulators
09/27/2012US20120245157 Oxazine derivatives
09/27/2012US20120245155 Fused heterocyclic compound having amino group
09/27/2012US20120245153 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
09/27/2012US20120245152 3-(biaryoxy)propionic acid derivative
09/27/2012US20120245149 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245144 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012CA2825966A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/26/2012EP2501705A1 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
09/26/2012EP2501700A1 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
09/26/2012CN101282981B Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
09/25/2012US8273895 NK1 antagonists
09/25/2012US8273890 Thiophene-imidazopyridines
09/25/2012CA2557371C Crystalline forms of a pharmaceutical compound
09/20/2012WO2012125613A1 Morpholine-spirocyclic piperidine amides as modulators of ion channels
09/20/2012WO2012122716A1 Tetracyclic xanthene derivatives and methods of use thereof for treatment of viral diseases
09/20/2012WO2011005295A8 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
09/20/2012US20120238751 Tricyclic gyrase inhibitors
09/20/2012US20120238745 Fluorescent dyes
09/20/2012US20120238599 Heterocyclic compounds as mek inhibitors
09/20/2012US20120238595 Therapeutic compounds
09/20/2012US20120238561 Morpholinothiazoles as alpha 7 positive allosteric modulators
09/20/2012US20120238546 Gamma secretase modulators
09/20/2012US20120238541 Pharmaceutical compounds
09/20/2012CA2829803A1 Morpholine-spirocyclic piperidine amides as modulators of ion channels
09/19/2012EP2500022A1 Antibacterial agent for drug-resistant bacteria, method for screening for same, and use of same
09/19/2012EP2499148A2 Conformationally constrained, fully synthetic macrocyclic compounds
09/19/2012EP2498600A1 Filamin a-binding anti-inflammatory analgesic
09/19/2012CN102686596A Azabicyclo[2.2.1] heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
09/19/2012CN102686595A Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
09/19/2012CN102686590A Pyrazoline dione derivatives as NADPH oxidase inhibitors
09/19/2012CN102686570A Mesoionic pesticides
09/19/2012CN102676413A Polar-region and deep-sea habitat actinomycete having strong killing effect for various pests and metabolites thereof
09/19/2012CN102675341A Dihydro-triazole and benzo two nitrogen heterocyclic ketones compound, processes for their preparation and pharmaceutical compositions comprising these compounds
09/18/2012US8268879 3-3-di-substituted-oxindoles as inhibitors of translation initiation
09/18/2012US8268859 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
09/18/2012US8268852 Heterocyclic inhibitors of MEK and methods of use thereof
09/18/2012US8268819 Hexahydrooxazinopterine compounds
09/18/2012CA2554536C Crystalline forms of gaboxadol monohydrate or anhydrate
09/18/2012CA2492325C Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
09/13/2012WO2012120206A1 Novel dihydro-oxazolobenzodiazepinone derivatives, preparation method thereof and pharmaceutical compositions containing same
09/13/2012WO2012120141A1 Π (pi)-conjugated fluoroionophores and method for determining an alkali ion
09/13/2012WO2011092564A8 Process for the preparation of temsirolimus and its intermediates
09/13/2012US20120232073 Fused bicyclic pyrimidine derivatives and methods of use thereof
09/13/2012US20120232072 Imidazopyridine derivatives
09/13/2012US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/13/2012US20120232065 Dihydro-oxazolobenzodiazepinone compounds, a process for there preparation and pharmaceutical compositions containing them
09/13/2012US20120232057 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
09/13/2012US20120232052 Aryl carboxamide derivatives as ttx-s blockers
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 220